# MilliporeSigma

MilliporeSigma is a Corporate Investor based in Burlington, United States.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Burlington, United States
- **Region:** North America
- **Address:** 400 Summit Drive, Burlington, MA, United States
- **Founded:** 1975
- **Assets under management:** Undisclosed
- **Website:** milliporesigma.com
- **LinkedIn:** https://www.linkedin.com/company/milliporesigma

## Regulatory record

- **Reports private funds:** No

## About

MilliporeSigma specializes in life sciences, offering tools and services for research and pharmaceutical development. Its products cater to scientists, while its services support contract development and manufacturing organizations (CDMO) and contract testing across various modalities. The company was founded in 1975 and is headquartered in Burlington, Massachusetts, having been acquired by Merck in September 2014.

## Sectors

- Life Sciences
- Biotech
- Pharmaceuticals

## Offices

- St. Louis, MO
- Carlsbad, CA
- Jaffrey, NH
- Darmstadt, Germany
- Daejeon, South Korea

## People

- Karen Madden — Chief Technology Officer

## Questions

### Who makes investment decisions at MilliporeSigma?

Capital allocation decisions at MilliporeSigma are integrated into the strategic planning process of its parent company, Merck KGaA, Darmstadt, Germany. The firm does not operate a standalone investment committee or publish a roster of dedicated investment professionals. Technology roadmapping is influenced by CTO Karen Madden, who represents the firm on the board of the Analytical, Life Science, and Diagnostics Association.

### What sectors does MilliporeSigma focus on?

The firm concentrates on life sciences tools, bioprocessing equipment, cell and gene therapy manufacturing, and laboratory services. It does not invest in therapeutic drug development itself, maintaining a clear separation between its enabling-services role and the end-market risk of its pharma customers. Corporate partnerships with firms like Lotte Biologics and Siemens reflect this infrastructure-and-services posture.

### Where is MilliporeSigma's capital deployed physically?

MilliporeSigma operates major industrial sites in Carlsbad, California (viral and gene therapy), St. Louis, Missouri (antibody-drug conjugate bioconjugation), Jaffrey, New Hampshire (manufacturing), Darmstadt, Germany (quality control), and Daejeon, South Korea (bioprocessing). Its commercial headquarters is at 400 Summit Drive in Burlington, Massachusetts.

### What is the relationship between MilliporeSigma and the Millipore Foundation?

The Millipore Foundation and the MilliporeSigma Corporate Giving Program conduct grantmaking separate from the firm's commercial investment activities. These philanthropic arms focus on science education and community support, with governance structures that maintain independence from the industrial capital-deployment decisions made by the commercial entity.

### Does MilliporeSigma participate in fund commitments alongside external GPs?

There is no public record of MilliporeSigma committing capital to third-party venture funds as a limited partner. Its external engagement pattern favors direct corporate partnerships and joint ventures, such as those with Siemens and Lotte Biologics, rather than blind-pool commitments to outside managers.

## Related profiles

- [Millesime Patrimoine](https://altss.com/profile/millesime-patrimoine)
- [Millstone Evans Group](https://altss.com/profile/millstone-evans-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/milliporesigma

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology